TY - JOUR
T1 - Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes
AU - Mebazaa, Alexandre
AU - Gheorghiade, Mihai
AU - Piña, Ileana L.
AU - Harjola, Veli Pekka
AU - Hollenberg, Steven M.
AU - Follath, Ferenc
AU - Rhodes, Andrew
AU - Plaisance, Patrick
AU - Roland, Edmond
AU - Nieminen, Markku
AU - Komajda, Michel
AU - Parkhomenko, Alexander
AU - Masip, Josep
AU - Zannad, Faiez
AU - Filippatos, Gerasimos
N1 - Funding Information:
Dr. Mebazaa has received honoraria from Abbott Laboratories, Guidant, and Edwards LifeSciences and has been a consultant for Abbott Laboratories, Orion Pharma, PDL BioPharma, and Sigma-Tau. Dr. Gheorghiade has received research grants from the National Institutes of Health, Otsuka Pharmaceutical Group, Sigma-Tau, Merck, and Scios Inc; has been a consultant to Debbio Pharm, Errekappa Terapeutici, GlaxoSmithKline, PDL BioPharma, and Medtronic; and has received honoraria from Abbott Laboratories, AstraZeneca, GlaxoSmithKline, Medtronic, Otsuka Pharmaceutical Group, PDL BioPharma, Scios, and Sigma-Tau. Dr. Piña has held consultancies for AstraZeneca, Novartis, Scios, and Solvay Pharmaceuticals and has received honoraria from AstraZeneca and GlaxoSmithKline. Dr. Follath has received honoraria from Abbott Laboratories. Dr. Rhodes has held a consultancy with Abbott Laboratories. The remaining authors have not disclosed any potential conflicts of interest.
PY - 2008/1
Y1 - 2008/1
N2 - Guideline recommendations for the prehospital and early in-hospital (first 6-12 hrs after presentation) management of acute heart failure syndromes are lacking. The American College of Cardiology/American Heart Association and European Society of Cardiology guidelines direct the management of these acute heart failure patients, but specific consensus on early management has not been published, primarily because few early management trials have been conducted. This article summarizes practical recommendations for the prehospital and early management of patients with acute heart failure syndromes; the recommendations were developed from a meeting of experts in cardiology, emergency medicine, and intensive care medicine from Europe and the United States. The recommendations are based on a unique clinical classification system considering the initial systolic blood pressure and other symptoms: 1) dyspnea and/or congestion with systolic blood pressure >140 mm Hg; 2) dyspnea and/or congestion with systolic blood pressure 100-140 mm Hg; 3) dyspnea and/or congestion with systolic blood pressure <100 mm Hg; 4) dyspnea and/or congestion with signs of acute coronary syndrome; and 5) isolated right ventricular failure. These practical recommendations are not intended to replace existing guidelines. Rather, they are meant to serve as a tool to facilitate guideline implementation where data are available and to provide suggested treatment approaches where formal guidelines and definitive evidence are lacking.
AB - Guideline recommendations for the prehospital and early in-hospital (first 6-12 hrs after presentation) management of acute heart failure syndromes are lacking. The American College of Cardiology/American Heart Association and European Society of Cardiology guidelines direct the management of these acute heart failure patients, but specific consensus on early management has not been published, primarily because few early management trials have been conducted. This article summarizes practical recommendations for the prehospital and early management of patients with acute heart failure syndromes; the recommendations were developed from a meeting of experts in cardiology, emergency medicine, and intensive care medicine from Europe and the United States. The recommendations are based on a unique clinical classification system considering the initial systolic blood pressure and other symptoms: 1) dyspnea and/or congestion with systolic blood pressure >140 mm Hg; 2) dyspnea and/or congestion with systolic blood pressure 100-140 mm Hg; 3) dyspnea and/or congestion with systolic blood pressure <100 mm Hg; 4) dyspnea and/or congestion with signs of acute coronary syndrome; and 5) isolated right ventricular failure. These practical recommendations are not intended to replace existing guidelines. Rather, they are meant to serve as a tool to facilitate guideline implementation where data are available and to provide suggested treatment approaches where formal guidelines and definitive evidence are lacking.
KW - Acute
KW - Emergency treatment
KW - Heart failure
UR - http://www.scopus.com/inward/record.url?scp=37549034629&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=37549034629&partnerID=8YFLogxK
U2 - 10.1097/01.CCM.0000296274.51933.4C
DO - 10.1097/01.CCM.0000296274.51933.4C
M3 - Article
C2 - 18158472
AN - SCOPUS:37549034629
SN - 0090-3493
VL - 36
SP - S129-S139
JO - Critical care medicine
JF - Critical care medicine
IS - 1 SUPPL.
ER -